EGFR and non-small cell lung carcinoma: Studies have shown FBLN1C binds HB-EGF (Brooke et al., 2002), which is a prominently overexpressed ligand for EGFR in NSCLC (Hsieh et al., 2017; Yotsumoto et al., 2017).